TY - JOUR T1 - Brazil Health Care System preparation against COVID-19 JF - medRxiv DO - 10.1101/2020.05.09.20096719 SP - 2020.05.09.20096719 AU - Lincoln Luís Silva AU - Amanda de Carvalho Dutra AU - Pedro Henrique Iora AU - Guilherme Luiz Rodrigues Ramajo AU - Gabriel Antônio Fernandes Messias AU - Iago Amado Peres Gualda AU - Joao Felipe Hermann Costa Scheidt AU - Pedro Vasconcelos Maia do Amaral AU - Catherine Staton AU - Thiago Augusto Hernandes Rocha AU - Luciano de Andrade AU - João Ricardo Nickenig Vissoci Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/15/2020.05.09.20096719.abstract N2 - Background The coronavirus disease outbreak from 2019 (COVID-19) is associated with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a highly contagious virus that claimed thousands of lives around the world and disrupted the health system in many countries. The assessment of emergency capacity in every country is a necessary part of the COVID-19 response efforts. Thus, it is extremely recommended to evaluate the health care system to prepare the country to tackle COVID-19 challenges.Methods and Findings A retrospective and ecological study was performed with data retrieved from the public national healthcare database (DATASUS). Numbers of intensive care unit and infirmary beds, general or intensivists physicians, nurses, nursing technicians, and ventilators from each Regional Health Unity were extracted, and the beds per health professionals and ventilators per population rates were assessed. The accessibility to health services was also performed using a spatial overlay approach to verify regions that lack assistance. It was found that Brazil lacks equity, integrity, and may struggle to assist with high complexity for the COVID-19 patients in many regions of the country.Conclusions Brazil’s health system is insufficient to tackle the COVID-19 in some regions of the country where the coronavirus may be responsible for high rates of morbidity and mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe present work received no funding.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available at http://tabnet.datasus.gov.br/cgi/tabcgi.exe?cnes/cnv/prid02mg.def http://tabnet.datasus.gov.br/cgi/tabcgi.exe?cnes/cnv/prid02mg.def ER -